Speakers:
Dr Andrew Wardley, Consultant medical oncologist, Christies in Manchester
Kate Law, Head of Clinical Trials, Cancer Research UK
Cancer experts answered questions from journalists about the draft guidance published by NICE (the National Institute for Health and Clinical Excellence) on Herceptin for use in early breast cancer.